share_log
Benzinga ·  May 9 07:54
Annovis Reports Completion Of Data Cleaning For Phase III Study Of Buntanetap In Patients With Early Parkinson's Disease; Topline Efficacy Data Is Expected In June
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment